Novacyt (ALNOV)

Currency in EUR
0.4310
+0.0250(+6.16%)
Real-time Data·
Unusual trading volume
ALNOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.41050.4500
52 wk Range
0.38000.7350
Key Statistics
Prev. Close
0.406
Open
0.42
Day's Range
0.4105-0.45
52 wk Range
0.38-0.735
Volume
1.43M
Average Volume (3m)
118.91K
1-Year Change
-27.9242%
Book Value / Share
0.67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALNOV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Novacyt News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Novacyt Company Profile

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.

Employees
234
Market
France

Compare ALNOV to Peers and Sector

Metrics to compare
ALNOV
Peers
Sector
Relationship
P/E Ratio
−0.9x−1.4x−0.6x
PEG Ratio
−0.05−0.020.00
Price/Book
0.6x1.9x2.6x
Price / LTM Sales
1.3x7.0x3.4x
Upside (Analyst Target)
-24.2%41.8%
Fair Value Upside
Unlock4.4%4.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Novacyt (ALNOV) Income Statement & Profits

People Also Watch

4.00
DBV
-6.33%
3.914
VLS
-4.68%
14.530
FRVIA
+0.59%
5.48
GNFT
-1.44%
10.88
ALCRB
-1.89%

FAQ

What Is the Novacyt (ALNOV) Share Price Today?

The live Novacyt share price today is 0.4310

What Stock Exchange Does Novacyt (ALNOV) Trade On?

Novacyt is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Novacyt?

The stock symbol (also called a 'ticker') for Novacyt is "ALNOV."

What Is the Current Novacyt Market Cap?

As of today, Novacyt market capitalisation is 30.60M.

What Is Novacyt's (ALNOV) Earnings Per Share (TTM)?

The Novacyt EPS is currently -0.41 (Trailing Twelve Months).

When Is the Next Novacyt Earnings Date?

Novacyt's next earnings report will be released on 22 Apr 2026.

Is ALNOV a Buy or Sell From a Technical Analyst Perspective?

Based on today's Novacyt moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Novacyt Stock Split?

Novacyt has split 0 times. (See the ALNOV stock split history page for full effective split date and price information.)

How Many Employees Does Novacyt Have?

Novacyt has 234 employees.

What is the current trading status of Novacyt (ALNOV)?

As of 26 Jan 2026, Novacyt (ALNOV) is trading at a price of 0.4310, with a previous close of 0.4060. The stock has fluctuated within a day range of 0.4105 to 0.4500, while its 52-week range spans from 0.3800 to 0.7350.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.